MIR3938

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR3938 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR3938 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR3938 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3938 expression acts as an unfavorable survival marker.

UCEC, KIRC, and KIRP are the cancer types where MIR3938 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECOSTertileAll0.1030.684<.001126view →
KIRCDFSTertileAll0.1300.796<.00190view →
KIRPDFSTertileAll0.1570.867<.00136view →
OVOSTertileII,III,IV0.4810.694.02036view →
BRCADFSTertileII,III,IV0.6990.942.00130view →
HNSCOSTertileAll0.5490.768.0446view →
Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR3938–UCEC (OS)

Kaplan–Meier survival curve for MIR3938 RNA-high vs -low samples in UCEC.

Open the UCEC breakdown →

Exploration